Safety/Efficacy Study of Drospirenone/Estradiol to Treat Postmenopausal Chinese Women With Vasomotor Symptoms.
Status:
Completed
Trial end date:
2007-10-01
Target enrollment:
Participant gender:
Summary
The study evaluates in Chinese post-menopausal women the combination of drospirenone 2 mg and
estradiol 1 mg for the treatment of climacteric symptoms, such as hot flushes (vasomotor
symptoms) and uro-genital complaints.